8-KFiled Aug 10, 8:00 PM ET

CalciMedica Announces Quarterly Results for Period Ended June 30, 2026

$CALC · CalciMedica, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

CalciMedica Announces Quarterly Results for Period Ended June 30, 2026

What Happened

  • CalciMedica, Inc. (CALC) filed a Form 8-K on August 11, 2026 (Item 2.02) to announce its results of operations and financial condition for the fiscal quarter ended June 30, 2026. The company issued a press release with the announcement, which is attached to the filing as Exhibit 99.1. The report was signed by CEO A. Rachel Leheny, Ph.D.

Key Details

  • Filing date: August 11, 2026 (Form 8-K, Item 2.02).
  • Reporting period: fiscal quarter ended June 30, 2026.
  • Press release attached as Exhibit 99.1 to the 8-K.
  • Report signed by A. Rachel Leheny, Ph.D., Chief Executive Officer.

Why It Matters

  • The 8-K formally notifies investors that CalciMedica has published its latest quarterly financial results; investors should read the attached press release for revenue, earnings (or loss), cash position, and operational updates. This information is material for assessing near-term financial performance and company progress.